For the Inventor, By the Inventor

Enter assignee name

Bethesda, MD, United States of America

National Institutes of Health (nih)

USPTO Granted Patents = 30

Forward Citations = 130

Loading Chart...

Loading Chart...

95 inventors (with patents filed for the assignee):

Nigel H Greig (2 out of 27 patents)

Gordon Powers (2 out of 23 patents)

Harold W Holloway (2 out of 17 patents)

4. Yves Pommier (2 out of 36 patents)

5. Donald K Ingram (2 out of 6 patents)

6. Keli K Agama (2 out of 5 patents)

7. Arnold Brossi (2 out of 25 patents)

8. Karen T Y Shaw (2 out of 4 patents)

9. Qiang-Sheng Yu (2 out of 4 patents)

10. Tada Utsuki (2 out of 4 patents)

11. Timothy T Soncrant (2 out of 6 patents)

12. Diane M Davidson (2 out of 4 patents)

13. Michael Alan Sturgess (2 out of 9 patents)

14. Mark Stanley Cushman (2 out of 37 patents)

15. Anthony J Giordano (2 out of 12 patents)

30 patents: Sort by Forward Citations

1. 11845955 - Scatter labeled imaging of microvasculature in excised tissue (SLIME) (2023-12-19),

2. 11771749 - KRAS peptide vaccine compositions and method of use (2023-10-03),

3. 11337753 - Tissue cutting systems and methods (2022-05-24),

4. 11135187 - Compositions and methods for treating diabetic retinopathy (2021-10-05),

5. 11041011 - Human alpha fetoprotein-specific murine T cell receptors and uses thereof (2021-06-22),

6. 10335491 - Catalytic delivery nanosubstrates (CDNS) for highly efficient delivery of biomolecules (2019-07-02),

7. 9911206 - Time efficient ASL imaging with segmented multiband acquisition (2018-03-06),

8. 9399660 - N-substituted indenoisoquinolines and syntheses thereof (2016-07-26),

9. 9388211 - N-substituted indenoisoquinolines and syntheses thereof (2016-07-12),

10. 9220706 - Inhibition of leukemic stem cells by PP2A activating agents (2015-12-29),

11. 8940690 - Synthetic conjugates and uses thereof (2015-01-27),

12. 8912159 - Analyzing semaphorin7a (Sema7A) levels for assessing cancer metastatic potential and methods of treatment (2014-12-16),

13. 8911739 - Methods of preventing rejection of transplanted tissue by administering anti-CD40L antibody and dendritic cells loaded with Hsp60sp peptide (2014-12-16),

14. 8877183 - Methods for treatment of ocular diseases (2014-11-04),

15. 8865411 - Methods of identifying modulators of TDP-43 mediated cellular toxicity (2014-10-21),

The National Institutes of Health (NIH), a part of the U.S. Department of Health and Human Services, is the nation's medical research agency. As the largest biomedical research funder in the world, NIH conducts and supports cutting-edge research to improve human health. NIH scientists investigate numerous diseases and medical conditions, examining the fundamental aspects of human biology and translating findings into medical breakthroughs. With a commitment to innovation and collaboration, NIH strives to enhance health outcomes and alleviate suffering.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

30 Patents

#15 in Bethesda, MD

#129 in Maryland

#10,859 in US

#21,180 in the World

Bethesda, MD, United States of America

National Institutes of Health (nih)

Forward Citations = 130

95 inventors:

Nigel H Greig (2 out of 27 patents)

Gordon Powers (2 out of 23 patents)

Harold W Holloway (2 out of 17 patents)

4. Yves Pommier (2 out of 36 patents)

5. Donald K Ingram (2 out of 6 patents)

Please report any incorrect information to support@idiyas.com

Loading…